The store will not work correctly when cookies are disabled.
5-Nitrofuran-2-yl-N-benzylnitrone
ID: ALA4876294
PubChem CID: 164627975
Max Phase: Preclinical
Molecular Formula: C12H10N2O4
Molecular Weight: 246.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)o1
Standard InChI: InChI=1S/C12H10N2O4/c15-13(8-10-4-2-1-3-5-10)9-11-6-7-12(18-11)14(16)17/h1-7,9H,8H2/b13-9-
Standard InChI Key: NWUJHBAYXHVHSG-LCYFTJDESA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
22.4515 -4.3709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8348 -3.1185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6600 -3.1185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9197 -2.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2494 -1.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5835 -2.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7965 -2.0755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6254 -1.2682 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1824 -2.6293 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1460 -3.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9668 -3.7026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3017 -2.9488 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1139 -5.1255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2954 -5.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9619 -5.9602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4452 -6.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2700 -6.5358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6039 -5.7819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 2 1 0
7 8 1 0
7 9 2 0
6 7 1 0
3 10 1 0
10 11 2 0
11 12 1 0
11 1 1 0
1 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M CHG 4 7 1 8 -1 11 1 12 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.22 | Molecular Weight (Monoisotopic): 246.0641 | AlogP: 2.32 | #Rotatable Bonds: 4 |
Polar Surface Area: 82.35 | Molecular Species: ACID | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: -4.10 | CX Basic pKa: ┄ | CX LogP: 1.34 | CX LogD: 1.34 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.27 | Np Likeness Score: -0.75 |
References
1. Pacheco JDS, Costa DS, Cunha-Júnior EF, Andrade-Neto VV, Fairlamb AH, Wyllie S, Goulart MOF, Santos DC, Silva TL, Alves MA, Costa PRR, Dias AG, Torres-Santos EC.. (2021) Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity., 12 (9.0): [PMID:34531949] [10.1021/acsmedchemlett.1c00193] |